JUPITER, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and to develop and manufacture prophylactic, therapeutic, and nutritional biopharmaceutical products for human and animal health and wellness, today announced that its management will be attending the following industry events during the month of April 2024.
World Vaccine Congress | Washington
Walter E. Washington Convention Center, Washington D.C.
April 3, 2024
Booth #551
Presentation: New Vaccine Development “The thermophilic filamentous fungus, C1 - an extraordinary platform for the production of prophylactics for humans and animals”
The Future of Protein Production
McCormick Place, Chicago
April 24-25, 2024
If you would like to schedule a meeting with one of our management members at any of these events, please contact Heidi Zosiak at hzosiak@dyadic.com.
https://www.globenewswire.com/news-release/2024/03/27/2853162/0/en/Dyadic-to-Attend-Industry-Events-in-April.html